Bispecific Antibodies Against CD3EPSILON and ROR1
Copyright © Targeted News Service 2024
2024-04-09
ALEXANDRIA, Virginia, April 9 -- BRISTOL-MYERS SQUIBB COMPANY, Princeton, New Jersey has been assigned a patent (No. US 11952421 B2, initially filed Oct. 8, 2015) developed by sixteen inventors Minh Diem Vu, Wollerau, Switzerland; Klaus Strein, Weinheim, Germany; Oliver Ast, Bassersdorf, Switzerland; Tanja Fauti, Zurich, Switzerland; Anne Freimoser-Grundschober, Zurich, Switzerland; Ralf Hosse, Cham, Switzerland; Christian Klein, Bonstetten, Switzerland; Ekkehard Moessner, Kreuzlingen, Switzerla . . .